Protein synthesis and the folding of the newly synthesized proteins into the correct three-dimensional structure are coupled in cellular compartments of the exocytosis pathway by a process that modulates the phosphorylation level of eukaryotic initiation factor-2a (eIF2a) in response to a stress signal from the endoplasmic reticulum (ER) 1, 2 . Activation of this process leads to reduced rates of initiation of protein translation during ER stress 3 . Here we describe the cloning of perk, a gene encoding a type I transmembrane ER-resident protein. PERK has a lumenal domain that is similar to the ER-stress-sensing lumenal domain of the ER-resident kinase Ire1, and a cytoplasmic portion that contains a protein-kinase domain most similar to that of the known eIF2a kinases, PKR and HRI. ER stress increases PERK's protein-kinase activity and PERK phosphorylates eIF2a on serine residue 51, inhibiting translation of messenger RNA into protein.
These properties implicate PERK in a signalling pathway that attenuates protein translation in response to ER stress.
In eukaryotic cells, the folding of proteins that are destined to be secreted or membrane-bound takes place in the ER. This process is impeded when cells are deprived of essential nutrients or energy sources or exposed to toxins that perturb the specialized environment of the ER 4 . The accumulation of incorrectly folded proteins triggers an ER-stress response that has at least two distinct components. The ®rst, known as the unfolded-protein response (UPR), consists of the transcriptional induction of genes that encode ERresident proteins such as Grp78, Grp94 and protein disulphide isomerase. These proteins are believed to promote the folding of newly synthesized peptides in the ER lumen 5, 6 . The second component consists of a profound and rapid repression of protein synthesis 3 . Both responses can be rationalized in terms of the need to relieve ER stress: the ®rst response increases the capacity of the ER to actively fold proteins and the second decreases the demands made on the organelle by attenuating protein-synthesis rates 2 . The mediators of the UPR have been well characterized, ®rst in yeast 7, 8 and, more recently, in mammalian cells 9, 10 . The sensor of ER stress in both types of cell is an ER-resident transmembrane kinase, IRE1, which transduces a lumenal signal imparted by the presence of incorrectly folded proteins to a nuclear event that results in the increased transcription of the previously mentioned genes 11 . Reduced protein synthesis in response to ER stress is associated with polysome disassembly and correlates with increased phosphorylation of eIF2a (refs 1, 3) . Phosphorylated eIF2a interferes with the formation of an active 43S translation-initiation complex 12 and expression of a non-phosphorylatable mutant eIF2a (with a mutation of residue S51 to A; S51A) attenuates translational inhibition by ER stress 13 . Two different eIF2a kinases have been identi®ed in mammalian cells, haem-regulated eIF2a kinase (HRI) 14 and the interferon-inducible RNA-dependent protein kinase (PKR) 15 . Ca 2+ release from ER stores enhances the kinase activity of PKR 16 and dominant-negative mutant forms of PKR attenuate the inhibition of translation mediated by Ca 2+ release 13 . Although both of these results are consistent with a role for PKR in translational inhibition by ER stress, the level of inhibition of protein synthesis is nearly the same in wild-type and pkr -/-cells (see below). This suggests the existence of alternative eIF2a kinases that may respond to ER stress.
A search of the nucleotide databases (GenBank) identi®ed a Caenorhabditis elegans cosmid, CEF46C3, that contains a gene encoding a predicted type I transmembrane protein (one with its amino terminus in the lumen) with a cytoplasmic portion that has a protein-kinase domain most similar to that of PKR and HRI and an external/lumenal domain that shares blocks of identity with C. elegans and mammalian Ire1. A human expressed sequence tag (EST) that encodes a peptide fragment with similarity to this C. elegans protein was used as a hybridization probe to clone a full-length complementary DNA encoding a murine homologue. The murine protein, of 1,114 residues, is ubiquitously expressed and has the same predicted type I transmembrane topology and ,30% overall identity to the C. elegans protein. Its N terminus has blocks of identity with mammalian Ire1, totalling 20% identity, and its carboxy terminus is ,40% identical to PKR (Fig. 1a, b) . A C-terminal Myc-tagged derivative of the full-length protein, when expressed in COS-1 cells, co-localized with endogenous ribophorin (an ER-membrane marker; Fig. 1c ). Increased mobility of the metabolically labelled protein doublet in immunoprecipitates treated with either endoglycosidase H or peptide N-glycosidase F indicates that it is a glycoprotein that is not transported to the distal Golgi complex and resides in the ER. We do not known why there are two species of the protein in the transfected cells (Fig. 1d) . On the basis of its similarity to PKR and its localization in the ER membrane, we named the protein PERK (for PKR-like ER kinase). We proposed that PERK, like Ire1, might respond to ER-stress signals and transduce these to changes in protein-synthesis rates through phosphorylation of eIF2a.
The puri®ed kinase domain of PERK, expressed as a fusion protein with glutathione-S-transferase (GST) in Escherichia coli undergoes autophosphorylation in vitro (Fig. 2a) . The active kinase phosphorylates puri®ed eIF2a effectively, indicating that the latter is a direct substrate (Fig. 2a, middle) . Phosphorylation of eIF2a takes place on S51 (Fig. 2b) , the same residue that is targeted by PKR and HRI 12 . Treatment of translation-competent reticulocyte lysate with puri®ed, bacterially expressed PERK leads to a profound inhibition in mRNA translation. Replacing K618 of PERK with alanine (K618A), a mutation that abolishes the ability of the protein to undergo autophosphorylation or to phosphorylate eIF2a (Fig. 2a , lane 2, top and middle), also abolishes its ability to inhibit translation (Fig. 2c, lane 2) . Cells transfected with PERK expression plasmids accumulate large quantities of the protein, and when levels of expression reach a certain threshold PERK's kinase activity is activated (Fig. 3c, compare lanes 2, 9) . This correlates with profound inhibition of mRNA translation (Fig. 2d, e) , indicating that the effects of PERK on protein translation observed in vitro in the reticulocyte lysate also occur in cells in vivo.
Mouse embryonic ®broblasts that are nullizygous for pkr are not impaired in their ability to reduce levels of protein synthesis when treated with agents that induce ER stress (Fig. 3a) . This indicates that another eIF2a kinase, perhaps PERK, may be involved in the attenuation of translation under these circumstances. Results of metabolic labelling experiments show that PERK is a phosphoprotein. In response to ER stress, it undergoes hyperphosphorylation and an associated shift in mobility during SDS±polyacrylamide-gel electrophoresis (Fig. 3b) . The shift is not observed for the inactive K618A mutant, is reduced by dephosphorylation in vitro and correlates with the autokinase activity of immunoprecipitated PERK (Fig. 3b, c) . These ER-stress-induced changes in PERK are consistent with intermolecular or intramolecular autophosphorylation, as has been suggested for the activation of the other known eIF2a kinases, HRI 17 and PKR 15 . The stress-activated conformational shift in PERK is independent of synthesis of new PERK protein (Fig. 3c, lane 4) , and treatment with arsenite, heat-shock or irradiation with ultraviolet lightÐconditions that trigger a cytoplasmic but not an ER stress response 2 Ðinduce only a minimal shift in PERK's mobility (Fig. 3c , lanes 5±7). Thus the change in conformation is a post-translational modi®cation of PERK that correlates with the ER-stress-dependent activation of the kinase.
The structural similarity between PERK and Ire1 indicates that both proteins may use a similar mechanism to transduce ER stress. This theory is supported by the observation that overexpression of the lumenal domain of PERK interferes with the induction of the UPR marker chop 18, 19 by ER stress (Fig. 3d) - parallel yet distinct pathways 20 . Our ®ndings suggest considerable homology between the two processes: both are initiated by transmembrane ER-resident kinases, Ire1 or PERK, which have similar lumenal domains, and both kinases undergo ER-stress-induced activation, a step that may involve an activating autophosphorylation event 21, 22 (Fig. 3) . Once activated, however, the two kinases appear to deliver distinct signals. On the basis of comparisons with yeast, mammalian Ire1 probably acquires endonuclease activity to cleave speci®c mRNA substrates 9 and effect enhanced expression of upstream activators of the UPR 23 . PERK, on the other hand, phosphorylates eIF2a and attenuates translation. Thus, in mammalian cells two signalling pathways that are responsive to ER stress appear to have evolved by appending different effector functions to otherwise similarly structured upstream transducers. Note added in proof : The rat orthologue of PERK has recently been identi®ed as an elF2a kinase that is expressed at high levels in the pancreas, an organ that is heavily engaged in protein secretion and ER traf®cking 26 . This ®nding underscores the potential physiological signi®cance of PERK's role in coupling folding to translation. 
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Methods
Cloning of Perk cDNA. We used the insert from human EST clone IMAGE number 746909 as a hybridization probe to screen 3 3 10 6 clones from an unampli®ed NIH3T3 ®broblast cDNA library in l-Zap.express (Stratagene). We identi®ed 19 clones. Expression plasmids. A C-terminal Myc tag and K618A mutation were incorporated into PERK by altering the Perk cDNA by polymerase chain reaction. The modi®ed cDNAs were ligated into the pcDNA1/Amp expression vector (Invitrogen). PERK lacking the C terminus (PERKDC) was created by an internal SnaBI±SmaI deletion (removing amino acids 582±1,081 of the protein) of the Myc-tagged full-length cDNA. A bacterial expression plasmid encoding a GST-fusion protein with the cytoplasmic domain of PERK (amino acids 537±1,114) was constructed in pGEX 4T1 (Pharmacia). The puri®ed fusion protein, of relative molecular mass ,93,000 (M r ,93K), was used in the in vitro assays described below and to raise rabbit antisera. Cell culture and transfection. COS-1, NIH3T3 and pkr +/+ and pkr -/-mouse embryonic ®broblasts were maintained in DMEM supplemented with 10% fetal bovine serum. Unless otherwise indicated, cells were treated with 2 mg ml -1
tunicamycin for 4 h, 1 mM thapsigargin for 30 min, 100 mM sodium arsenite for 2 h, and heat-shock at 42 8C for 2 h; pretreatment was with 27 J m -2 ultraviolet light or 10 mg ml -1 anisomycin for 45 min. COS-1 cells were transfected with 3 mg plasmid DNA per 60-cm dish by the DEAE-Dextran method. NIH3T3 cells were transfected with 1 mg DNA per 35-mm dish using Lipofectamine Plus (Life Technologies). Immunoblots were performed with rabbit anti-PERK serum diluted 1:10,000 nearly as described 18 except that cell lysates were prepared in a HEPES±Triton-X100 buffer (see below) and contained 10 mg total protein. Immunostaining was done as described 10 .
Cell labelling and immunoprecipitation. Transfected COS-1 cells were starved for 30 min in methionine-free DMEM containing 10% dialysed fetal calf serum, then labelled for 2 h with 250 mCi ml -1 35 S-Translabel (ICN) in the same medium. Cells were lysed in RIPA buffer immediately after labelling ( Fig. 2d) or after a 4 h cold-chase in complete media (Fig. 1d) . The labelled protein was immunoprecipitated with the indicated antibodies and resolved by 6% SDS±PAGE. Where indicated, the immunopuri®ed PERK was digested for 16 h at 37 8C with 0.025 U endoglycosidase H or 0.25 U peptide N-glycosidase F according to the manufacturer's instructions (Boehringer). In vivo 32 P-labelling of PERK was performed by preloading 10-cm plates of NIH3T3 cells with 125 mCi ml -1 32 P-orthophosphate for 14 h before stress treatment and lysis in HEPES±Triton-X100 buffer (20 mM HEPES, pH 7.5, 150 mM NaCl, 1% Triton-X100, 10% glycerol, 1 mM EDTA, 10 mM sodium diphosphate, 100 mM NaF, 17.5 mM B-glycerophosphate, 1 mM phenylmethylsulphonyl¯uoride, 4 mg ml -1 aprotonin, and 2 mg ml -1 pepstatin A). Nuclei were removed by brief centrifugation and the extracts were adjusted to a ®nal concentration of 0.5% sodium deoxycholate and 0.1% SDS before immunoprecipitation with anti-PERK antiserum (1 ml).
In vitro phosphorylation. These reactions, containing immunopuri®ed or recombinant bacterially expressed wild-type or K618A mutant GST±PERK (50 ng), were done in 20 ml kinase buffer 24 at 30 8C for 30 min with either 5 mCi [g-32 P]ATP (4,500 Ci mmol -1 ; ICN; Fig. 2a, 3b ) or 0.1 mM unlabelled ATP (Fig. 2b) . Where indicated, the reactions contained ,10 ng partially puri®ed human eIF2a, which was immunoprecipitated from the supernatant after incubation (Fig. 2a) , or 0.5 ml in vitro-translated 35 S-methionine-labelled wildtype or mutant (S51A) eIF2a (TNT reticulocyte lysate, Promega; Fig. 2b ). The products in Fig. 2b were analysed by isoelectric focusing using Pharmalytes, pH 4±6.5, as described 25 . To measure translational inhibition by PERK, glutathione±Sepharose beads (1 ml bed volume) containing ,50 ng GST±PERK (wild-type or K618A) were pre-incubated for 1±15 min at room temperature with 12 ml of an in vitro translation mixture (Promega) before addition of 0.5 mg in vitro-transcribed capped luciferase mRNA. The labelled luciferase protein was resolved by 10% SDS±PAGE.
